Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERG
Shih‐Chung Huang(Kaohsiung Armed Forces General Hospital), Alexandra E. Gould(Takeda (United States)), Emily F. Calderwood(Millennium Engineering and Integration (United States)), Mansoureh Rezaei(Millennium Engineering and Integration (United States)), Jeffery Gaulin(Millennium Engineering and Integration (United States)), Paul D. Greenspan(Takeda (United States)), Misook Kim(Takeda (United States)), Saurabh Menon(Takeda (United States)), Katherine C. Brewer(Takeda (United States)), Steven Langston(Takeda (United States)), Roushan Afroze(Takeda (United States)), Hirotake Mizutani(Millennium Engineering and Integration (United States)), Li‐Ting Ma(Takeda (United States)), Dylan B. England(Takeda (United States)), Dong Mei Zhang(Millennium Engineering and Integration (United States)), Jouhara Chouitar(Millennium Engineering and Integration (United States)), Craig D. Fisher(Takeda (United States)), Sean J. Harrison(Millennium Engineering and Integration (United States)), M. D. Smith(Millennium Engineering and Integration (United States)), Sharmila Adhikari(Millennium Engineering and Integration (United States)), Katherine Galvin(Takeda (United States))
Cited by 10
Related Papers
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
|Molecular Cell|2010|461
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor
|Nature Chemical Biology|2017|228